Jei Man Ryu

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Composition. Top assignees: Dong Wha Pharmaceutical Co. Ltd., Arimed Inc., Aribio Co., Ltd.. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jei Man Ryu. Retrieved from https://idiyas.com/inventor/jei-man-ryu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 4)

% Patents Active = 52.9

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 20(Granted Patents)

Location History:

Anyang, KR (2015)
Anyang-si, KR (2011 - 2017)
Gyeonggi-do, KR (2011 - 2020)

Company Filing History:

9 out of 10

Dong Wha Pharmaceutical Co. Ltd.

Shin Poong Pharmaceutical Co., Ltd.

patents

5. 1 out of 9

Je Il Pharmaceutical Co., Ltd.

patents

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

Antimicrobial Agents

Thrombotic Diseases

Osteoporosis Treatment

Platelet Aggregation

Pharmaceutical Composition

Bone Fracture

Benzamidine Derivatives

RNA Viral Diseases

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12485116 - Pharmaceutical composition for preventing or treating epidemic RNA viral infectious disease (2025-12-02),

2. 10730886 - Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same (2020-08-04),

3. 9751840 - R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2017-09-05),

4. 9452158 - R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1 acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2016-09-27),

5. 9150576 - R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1 acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2015-10-06),

6. 8952164 - R-7-(3-aminomethy-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydo-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2015-02-10),

7. 8664240 - R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2014-03-04),

8. 8334277 - {4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenoxy}phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component (2012-12-18),

9. 8324238 - Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same (2012-12-04),

10. 8242152 - Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for the prophylaxis and treatment of osteoporosis (2012-08-14),

11. 8227496 - Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis (2012-07-24),

12. 8178688 - Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same (2012-05-15),

13. 8039635 - N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl) phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same (2011-10-18),

14. 8008329 - Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonate (2011-08-30),

15. 7964584 - Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt (2011-06-21),

Title: **Innovative Contributions of Jei Man Ryu in Pharmaceutical Patents**

Introduction

Jei Man Ryu is a distinguished inventor based in Anyang-si, South Korea, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 16 patents, Ryu has dedicated his career to developing innovative compounds and compositions aimed at improving healthcare outcomes.

Latest Patents

Ryu’s latest patents showcase his expertise in creating compounds that have profound effects on medical treatment. One notable invention is a novel compound that inhibits platelet aggregation, alongside its salts, offering a crucial advancement in the treatment of thrombotic diseases. This invention specifically targets shear stress-induced platelet aggregation, presenting new possibilities for pharmaceutical compositions containing this active ingredient. Another significant patent is the R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid with L-aspartic acid salt. This patent emphasizes a more soluble, less toxic antimicrobial agent that exhibits fewer side effects than traditional salts, thus enhancing its viability for both oral and injectable administration.

Career Highlights

Throughout his career, Jei Man Ryu has collaborated with notable companies, including Dong Wha Pharmaceutical Co. Ltd. and Arimed Inc. His work in these organizations has been pivotal in driving forward pharmaceutical innovations that have the potential to make a significant impact on public health.

Collaborations

Jei Man Ryu has worked alongside esteemed colleagues such as Jin Soo Lee and Dong Rack Choi. Their collaborative efforts have contributed to the successful development of innovative pharmaceutical solutions that address critical medical challenges.

Conclusion

In summary, Jei Man Ryu’s extensive portfolio of patents highlights his pivotal role as an inventor in the pharmaceutical industry. His groundbreaking research and innovative compounds not only enhance medical treatments but also signify a promising future for advancements in healthcare. The expertise and collaboration he has exhibited throughout his career continue to inspire future innovations in the field.

Profile summary based on public USPTO records.